- Home
- PWR vs EW Comparison
PWR vs EW Comparison
Compare PWR & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWR
- EW
- Stock Information
- Founded
- PWR 1997
- EW 1958
- Country
- PWR United States
- EW United States
- Employees
- PWR N/A
- EW N/A
- Industry
- PWR Engineering & Construction
- EW Industrial Specialties
- Sector
- PWR Industrials
- EW Health Care
- Exchange
- PWR Nasdaq
- EW Nasdaq
- Market Cap
- PWR 49.1B
- EW 42.5B
- IPO Year
- PWR 1998
- EW 2000
- Fundamental
- Price
- PWR $328.72
- EW $74.78
- Analyst Decision
- PWR Strong Buy
- EW Buy
- Analyst Count
- PWR 16
- EW 21
- Target Price
- PWR $322.86
- EW $79.40
- AVG Volume (30 Days)
- PWR 1.0M
- EW 5.6M
- Earning Date
- PWR 02-20-2025
- EW 02-04-2025
- Dividend Yield
- PWR 0.12%
- EW N/A
- EPS Growth
- PWR 15.31
- EW 193.69
- EPS
- PWR 5.41
- EW 6.89
- Revenue
- PWR $22,903,321,000.00
- EW $6,314,900,000.00
- Revenue This Year
- PWR $14.71
- EW N/A
- Revenue Next Year
- PWR $12.35
- EW $0.91
- P/E Ratio
- PWR $60.71
- EW $28.85
- Revenue Growth
- PWR 17.36
- EW 24.02
- 52 Week Low
- PWR $187.27
- EW $58.93
- 52 Week High
- PWR $350.19
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- PWR 49.17
- EW 62.35
- Support Level
- PWR $319.21
- EW $72.29
- Resistance Level
- PWR $343.44
- EW $74.58
- Average True Range (ATR)
- PWR 9.31
- EW 1.93
- MACD
- PWR -2.02
- EW 0.06
- Stochastic Oscillator
- PWR 44.18
- EW 91.36
About PWR Quanta Services Inc.
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under three reportable segments: electric power, renewables infrastructure, and underground utility and infrastructure.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.